The circuitry of the striatum is characterized by two organizational plans: the division into striosome and matrix compartments, thought to mediate evaluation and action, and the direct and indirect pathways, thought to promote or suppress behavior. The developmental origins of these organizations and their developmental relationships are unknown, leaving a conceptual gap in understanding the cortico-basal ganglia system. Through genetic fate mapping, we demonstrate that striosome-matrix compartmentalization arises from a lineage program embedded in lateral ganglionic eminence radial glial progenitors mediating neurogenesis through two distinct types of intermediate progenitors (IPs). The early phase of this program produces striosomal spiny projection neurons (SPNs) through fate-restricted apical IPs (aIPSs) with limited capacity; the late phase produces matrix SPNs through fate-restricted basal IPs (bIPMs) with expanded capacity. Notably, direct and indirect pathway SPNs arise within both aIPS and bIPM pools, suggesting that striosome-matrix architecture is the fundamental organizational plan of basal ganglia circuitry.
Pubmed ID: 30017396 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets Human SOX2
View all literature mentionsThis polyclonal targets TTF-1
View all literature mentionsThis polyclonal targets Human Ctip2
View all literature mentionsThis monoclonal targets CHAT
View all literature mentionsThis monoclonal targets Somatostatin
View all literature mentionsThis monoclonal targets Parvalbumin
View all literature mentionsThis monoclonal targets BrdU
View all literature mentionsThis monoclonal targets Neuronal Class III beta-Tubulin (TUJ1) Purified
View all literature mentionsThis polyclonal targets Ki67 Antigen
View all literature mentionsThis polyclonal targets Tyrosine Hydroxylase
View all literature mentionsThis polyclonal targets Calbindin D-28K
View all literature mentionsThis polyclonal targets Synthetic rat MOR1 (384-398)
View all literature mentionsThis polyclonal targets RFP Pre-adsorbed
View all literature mentionsMus musculus with name B6;129S4-Dlx1tm1(cre/ERT2)Zjh/J from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J from IMSR.
View all literature mentionsMus musculus with name B6;129S-Gt(ROSA)26Sortm65.1(CAG-tdTomato)Hze/J from IMSR.
View all literature mentionsMus musculus with name STOCK Nkx2-1tm2.1(flpo)Zjh/J from IMSR.
View all literature mentionsMus musculus with name B6.C-Tg(CMV-cre)1Cgn/J from IMSR.
View all literature mentionsMus musculus with name STOCK Ascl1tm1.1(Cre/ERT2)Jejo/J from IMSR.
View all literature mentions